Delving into the Latest Updates on Tigermed Australia Pty Ltd. with Synapse

概览

关联

4

项与 Tigermed Australia Pty Ltd. 相关的临床试验

NCT06867796

/ Not yet recruiting临床1期

A Phase 1 Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of TL-001 in Healthy Adult Participants

The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.

开始日期2025-04-01

申办/合作机构

帆礼生物技术（武汉）有限公司

[+1]

ACTRN12622001339741

/ Recruiting临床1期

A Phase I, Open-label, Multicenter, First in Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients with Advanced Malignancies

开始日期2023-03-13

申办/合作机构

Tigermed Australia Pty Ltd.

NCT04629131

/ Completed临床1期

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Intramuscular Administration of a Single Dose of TNM002 in Healthy Subjects

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics properties of TNM002 following a single intramuscular dose in healthy adult subjects.

开始日期2020-11-25

申办/合作机构